Verastem Oncology
VSTM
#6412
Rank
โ‚ฌ0.67 B
Marketcap
8,90ย โ‚ฌ
Share price
-2.26%
Change (1 day)
79.41%
Change (1 year)

Revenue for Verastem Oncology (VSTM)

Revenue in 2025 (TTM): โ‚ฌ11.39 Million

According to Verastem Oncology 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ11.49 Million. In 2024 the company made a revenue of โ‚ฌ9.6 Million an increase over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Verastem Oncology from 2011 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ11.39 M18.55%
2024 โ‚ฌ9.6 M
2023 N/A-100%
2022 โ‚ฌ2.42 M33.5%
2021 โ‚ฌ1.81 M-97.48%
2020 โ‚ฌ71.96 M361.86%
2019 โ‚ฌ15.58 M-33.28%
2018 โ‚ฌ23.35 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Curis
CRIS
โ‚ฌ10 M-12.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ53.92 B 469,187.69%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ11.82 B 102,787.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ36.37 B 316,461.61%๐Ÿ‡ฌ๐Ÿ‡ง UK